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Abstract: We encountered an undescribed histologic feature of papillary urothelial neoplasms: “urothelial eddy”, 
which was histologically reminiscent of squamous eddy of irritated follicular keratosis of the skin. A review of 756 
patients with transurethral resection of bladder tumor revealed 10 patients (1.3%) of papillary urothelial neoplasms 
with urothelial eddies. All cases were male with a median age of 65 years. Urothelial eddies were characterized 
by small ovoid nests of ovoid to spindle cells arranged in an onion-skin pattern with fine cytoplasmic processes 
within wide intercellular space. The cytoplasmic processes mimicked intercellular bridges but ultrastructurally were 
cytoplasmic microvillous projections. They were of papillary urothelial neoplasm of low malignant potential in seven 
patients and low-grade urothelial carcinoma in three patients. Nine patients presented as non-invasive tumor and 
one patient showed microinvasion within papillary stalks. Six patients showed an inverted growth pattern. Their im-
munoprofile was more similar to that of conventional urothelial carcinoma rather than squamous cell carcinoma: 
high expressions of GATA3, S100P, uroplakin III, and cytokeratin 7; and low expressions of high molecular weight 
cytokeratin and p53. The Ki-67 labeling index was low (mean and median values, 2% each). During the follow-up 
period (mean, 88.7 months), four patients, including the microinvasive patient, showed recurrence with the same 
grade and stage but neither progressed into muscle-invasive tumor nor caused death. Our results suggest that 
urothelial eddy is a rare aberrant histology of papillary urothelial neoplasms with indolent behavior and should be 
discriminated from squamous differentiation of urothelial carcinoma, which has a poor prognosis. 
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Introduction
The prognosis of urothelial carcinoma is depen-
dent on tumor stage and grade, as well as spe-
cific morphologic features including histologic 
variants showing divergent differentiation [1]. 
Urothelial carcinoma has a propensity for aber-
rant differentiation and the most common his-
tologic variant is squamous differentiation, 
which is characterized by intercellular bridges 
and/or keratinization [1-3]. Because it is a poor 
prognostic factor in urothelial carcinoma and 
portends resistance to conventional anticancer 
treatment for urothelial carcinoma, recognizing 
the squamous differentiation has important 
clinical significance for proper management of 
these patients [2, 4, 5]. 
During a histologic review of bladder cancer 
patients, we encountered a distinct morpholog-
ic pattern of papillary urothelial neoplasm. We 
designated it as urothelial eddy, because it is 
morphologically similar to squamous eddy seen 
in irritated follicular keratosis of the skin. 
Although it is reminiscent of squamous differ-
entiation, urothelial eddy is urothelial in nature 
and the tumor appears to follow an indolent 
clinical course. The aim of this study was to 
characterize in detail both the pathologic fea-
tures and clinical outcomes of papillary urothe-
lial neoplasms with urothelial eddies.
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Materials and methods 
Patient selection and clinical data
This study was approved by the Institutional 
Review Board of Asan Medical Center (2013-
0027). A slide review of 756 patients who 
underwent transurethral resection of bladder 
tumor (TURBT) at Asan Medical Center from 
1996 to 2006 revealed 10 patients with papil-
lary urothelial neoplasms with urothelial eddies. 
To characterize the immunohistochemical pro-
file of these tumors, 22 patients with conven-
tional urothelial carcinoma, which were ran-
domly matched to patients of papillary urothelial 
neoplasms with urothelial eddies for age, sex, 
tumor-node-metastasis (TNM) stage, tumor 
grade, and TURBT year, were included as a con-
trol group. In addition, 11 patients with pure 
squamous cell carcinoma of the urinary blad-
der were included as control group of malignant 
counterpart of squamous eddy. 
Patient clinical information, including follow-up 
data and cystoscopic and radiological findings, 
was obtained from electronic medical records. 
Survival data were retrieved from the 
Department of Medical Records at the Asan 
Medical Center. The tumor grade and stage 
were assigned according to the WHO 1973 and 
WHO/ISUP 2004 classifications and the 
American Joint Committee on Cancer (AJCC) 
Staging System, 7th edition, respectively [1, 6]. 
Tissue microarray construction
Tissue microarray (TMA) blocks were generated 
from the formalin-fixed paraffin-embedded tis-
sue blocks of TURBT specimens, which had 
been harvested at initial diagnosis. They were 
constructed using a manual tissue microarray-
er (Beecher Instruments, Silver Spring, MD) 
and composed of 1 mm diameter cores of pap-
illary urothelial neoplasms with urothelial 
eddies and 2 mm diameter cores of control 
tumors. A representative three cores of the 
tumor tissues for each patient were included in 
the TMA blocks.
Immunohistochemistry
An immunohistochemical study was performed 
using urothelial lineage markers (GATA3, 
S100P, and uroplakin III) and markers expressed 
in various neoplasms, including urothelial neo-
plasm (thrombomodulin, cytokeratins 7 (CK7) 
and 20 (CK20), high molecular weight cytokera-
tin (HMWCK), p53, p63, and Ki-67). The prima-
ry antibodies used in this study are summarized 
in Table 1. Immunohistochemical staining was 
performed using a polymer-based system and 
an autostainer (Ventana Medical Systems, Inc., 
Tucson, AZ). Diaminobenzidine was used as a 
chromogen and the tissues were counter-
stained with Mayer’s hematoxylin. Appropriate 
positive control tissues for each antibody were 
included. 
All TMA slides were evaluated by two indepen-
dent pathologists (MSK. and YMC.), both of 
whom were blinded to the associated clinical 
and pathological information. The expression 
of the markers was recorded as average per-
centages of positive cells in all cores using 
semiquantitative eyeball measurement. Pati- 
ents with greater than or equal to 5% positive 
Table 1. Primary antibodies studied in this study and their subcellular expression
Antibody Clone Dilution Company Subcellular location
GATA3 L50-823 1:600 Biocare Medical, Concord, CA Nucleus
S100P Polyclonal Prediluted Cell Marque, Rocklin, CA Nucleus
Uroplakin III AU1 Prediluted Cell Marque, Rocklin, CA Cell membrane
Thrombomodulin 1009.3 1:50 Dako Corp., Carpinteria, CA Cell membrane
Cytokeratin 7 OV-TL 12/30 1:200 Dako Corp., Carpinteria, CA Cytoplasm
Cytokeratin 20 Ks 20.8 1:200 Dako Corp., Carpinteria, CA Cytoplasm
High molecular weight 
cytokeratin 34bE12 1:100 Dako Corp., Carpinteria, CA Cytoplasm
p63 7JUL 1:200 Novocastra, Newcastle, UK Nucleus
p53 DO-7 1:100 Dako Corp., Carpinteria, CA Nucleus
Ki-67 7B11 1:200 Zymed, CA Nucleus
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cells were regarded as positive except for uro-
plakin III, CD20, and Ki-67, for which the pres-
ence of any positive cells was regarded as posi-
tive patient.
Electron microscopy
Three representative patients with papillary 
urothelial neoplasms with urothelial eddies 
were studied by electron microscopy using 
standard techniques. One patient with normal 
urothelial mucosa of the urinary bladder and 
one patient with normal squamous mucosa of 
the esophagus were also included for compari-
son. The submitted tissues were retrieved from 
paraffin blocks, deparaffinized, post fixed in 1% 
buffered osmium tetroxide, dehydrated, and 
embedded in Epon. Ultrathin sections of 1 µm 
thickness were stained with uranyl acetate-
lead citrate and examined with a JEOL 1200 
EX-II transmission electron microscope (Jeol, 
Tokyo, Japan).
Statistical analysis
The data were analyzed by PASW Statistics 18 
(SPSS Inc., Chicago, IL, USA) software. 
Crosstabs and one-way analysis of variance 
were used as required. Differences were 
regarded as statistically significant when 
P-values < 0.05.
Results
Clinical features of papillary urothelial neo-
plasms with urothelial eddies
The clinicopathologic features of the 10 
patients (1.3%) of papillary urothelial neo-
plasms with urothelial eddies are summarized 
in Table 2. All patients were male with a median 
age of 65 years (range, 45-79 years) and admit-
ted to this hospital because of gross hematu-
ria. On cystoscopic examination, all patients 
demonstrated papillary to pedunculated mass 
in the urinary bladder (Figure 1A). Six patients 
presented with a single mass, three patients 
with two masses, and one patient had multiple 
masses. The tumors varied in size from 3 mm 
to 45 mm with a mean size of 28 mm. All 
patients underwent TURBT to completely 
remove the grossly visible tumor. Four patients 
underwent subsequent intravesical instillation 
of Bacillus Calmette-Guérin (BCG), two of whom 
received mitomycin C. One additional patient 
was treated with intravesical epirubicin alone. 
The remaining five patients did not receive any 
intravesical treatment after TURBT. No patient 
underwent radical cystectomy.
Histologic features of papillary urothelial neo-
plasms with urothelial eddies
The 10 patients with papillary urothelial neo-
plasms with urothelial eddies demonstrated 
areas of both urothelial eddies and convention-
al urothelial tumor (Figure 1B-F). The urothelial 
eddy area ranged between 10% and 95% 
(mean, 66.5%). Six patients showed an inverted 
growth pattern of the tumor (mean, 40%; range, 
0-95%; Figure 1C). 
The urothelial eddies were characterized by 
small ovoid nests of cells arranged in an onion-
skin pattern (Figure 1D). Because of the pecu-
liar cellular arrangement, tumor cells varied in 
shape, from ovoid to spindle to polygonal with 
indented nuclei (Figure 1E). The cells showed 
wide intercellular space and fine cytoplasmic 
processes, which were projecting into the inter-
cellular space on high magnification and super-
ficially mimicking intercellular bridges (Figure 
1E). However, none of the patients showed 
keratinization. 
Eight patients were originally diagnosed as low-
grade papillary urothelial carcinoma (1973 
WHO grade 2) and two patients as papillary uro-
thelial neoplasm of low malignant potential 
(PUNLMP, 1973 WHO grade 1) by non-genitouri-
nary (GU) pathologists. When reviewed by a GU 
pathologist (YMC) for this study, five out of the 
eight low-grade patients were downgraded to 
PUNLMP. As a result, seven patients were grad-
ed as PUNLMP and three patients as low-grade 
urothelial carcinoma (Table 2). No patient was 
classified as high grade on original or revised 
grading. One patient showed multiple foci of 
microinvasion of tumor cells within the stalk of 
the papillae (Figure 1F). However, an in situ uro-
thelial carcinoma component, lymphatic tumor 
emboli, or proper muscle invasion was not 
observed in any patient.
Immunohistochemial features of papillary uro-
thelial neoplasms with urothelial eddies
The immunoprofile of papillary urothelial neo-
plasms with urothelial eddies is summarized in 
Table 3. Among the urothelial lineage markers, 
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Table 2. Clinicopathologic features of 10 patients with papillary urothelial neoplasms with urothelial eddies 
Cystoscopic features Pathologic features Follow-up
Patient
no.
Age
(yr)
Tumor
no.
Tumor
Size (mm)
pT
stage
Grade†
(original
/revised)
Inverted  
pattern
(%)
Urothelial  
eddy
(%)
Post-TURBT  
intravesical  
instillation
Period
(mo)
Recurrence 
no. Progression Survival
1 52 Single 20 Ta 1/1 95 95 None 28 0 No AWOD
2 64 Single 15-20 Ta 2/1 20 20 None 121 0 No DOOC (TA)
3 79 Multiple Up to 30 Ta 2/2 0 10 BCG 77 1 No AWOD
4 79 Single 30 Ta 2/2 0 90 None 95 1 No AWOD
5 56 Two 10 and 30 T1 2/2 10 70 BCG & mitomycin C 115 2 No AWOD
6 65 Two 3 and 15 Ta 1/1 95 70 BCG & mitomycin C 233 3 No AWOD
7 71 Two 10 and 30 Ta 2/1 90 80 None 2 0 No AWOD
8 65 Single 10 Ta 2/1 90 80 None 20 0 No DOOC (AGC)
9 45 Single 20 Ta 2/1 0 70 Epirubicin 99 0 No AWOD
10 66 Single 45 Ta 2/1 0 80 BCG 97 0 No AWOD
†1973 WHO classification is used for tumor grade because old patients were graded according to the classification. yr, years; no., number; mo, months; AWOD, alive without disease; 
DOOC, Died of other cause; TA, traffic accident; BCG, Bacillus Calmette-Guérin; AGC, advanced gastric cancer.
Table 3. Comparison of immunohistochemical profiles of papillary urothelial neoplasms with urothelial eddies, conventional urothelial carcinoma, 
and squamous cell carcinoma of the urinary bladder
Papillary urothelial neoplasms with
urothelial eddies
n = 10
Urothelial carcinoma
n = 22
Squamous cell carcinoma
n = 11 P-value
Positive patient
no. (%)
Mean expression 
% ± SD
Positive 
patient no. 
(%)
Mean expression  
% ± SD
Positive 
patient no. 
(%)
Mean expression 
% ± SD
Positive 
patient no. 
(%)†
Mean expression 
% ± SD‡
GATA3 8 (80) 34 ± 31 21 (96) 52 ± 32 0 (0) 0 ± 0 < 0.001 < 0.001
S100P 10 (100) 68 ± 11 22 (100) 67 ± 10 2 (18) 8 ± 9 < 0.001 < 0.001
Uroplakin III 5 (50) 2 ± 3 10 (46) 3 ± 4 0 (0) 0 ± 0 0.022 0.035
Thrombomodulin 4 (40) 12 ± 16 13 (59) 18 ± 10 7 (63) 13 ± 7 1.000 0.941
CK7 10 (100) 73 ± 12 21 (96) 90 ± 23 5 (46) 20 ± 31 0.001 < 0.001
CK20 4 (40) 1 ± 3 6 (28) 4 ± 13 0 (0) 0 ± 0 0.162 0.503
p63 10 (100) 55 ± 27 20 (91) 49 ± 36 7 (63) 47 ± 32 0.074 0.210
HMWCK 5 (50) 14 ± 24 10 (46) 19 ± 32 11 (100) 78 ± 33 0.005 < 0.001
p53 3 (30) 3 ± 4 5 (23) 6 ± 17 6 (55) 27 ± 35 0.086 0.017
Ki-67 5 (50) 2 ± 1 12 (55) 7 ± 11 6 (55) 9 ± 12 0.717 0.001
no., number; CK, cytokeratin; HMWCK, high molecular weight cytokeratin. †The significance was evaluated by linear by linear association. ‡The significance was evaluated by one-way 
analysis of variance.
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papillary urothelial neoplasms with urothelial 
eddies revealed a high expression of S100P in 
all patients (mean expression, 68%; range, 
50-100%) and GATA3 in eight patients (mean 
expression, 34%; range, 2-77%). Five patients 
showed uroplakin III expression, which was of a 
surface or focal membranous pattern (mean 
expression, 2%; range, 0-8%) as previously 
described [7]. Among the markers expressed in 
various tumors, papillary urothelial neoplasms 
with urothelial eddies showed strong and dif-
fuse expressions of CK7 (mean expression, 
73%; range, 57-100%) and p63 (mean expres-
sion, 55%; range, 27-95%) in all patients and 
focal expressions of thrombomodulin in four 
patients (mean expression, 12%; range, 0-57%) 
and HMWCK in five patients (mean expression, 
14%; range, 0-80%). CK20 and p53 were barely 
expressed in four patients (mean expression, 
1%; range, 0-8%) and three patients (mean 
expression, 3%; range, 0-10%), respectively. 
Five patients showed Ki-67 expression with a 
mean labeling index of 2% (median expression, 
2%; range, 0-4%). In the same tumors, immuno-
histochemical findings were identical in eddy 
areas and non-eddy areas.
The immunoprofile of papillary urothelial neo-
plasms with urothelial eddies was similar to 
conventional urothelial carcinoma cases but 
different from squamous cell carcinoma cases 
in expressions of GATA3, S100P, uroplakin III, 
CK7, HMWCK, and p53 (Figure 2). There were 
no differences in expressions of thrombomodu-
lin, CK20, and p63 between the papillary uro-
thelial neoplasm group with urothelial eddies 
and two control groups of conventional urothe-
lial carcinoma and squamous carcinoma. 
Interestingly, papillary urothelial neoplasms 
with urothelial eddies did not share a similar 
immunoprofile to that of squamous cell carci-
noma of the urinary bladder. The Ki-67 labeling 
index of papillary urothelial neoplasms with 
urothelial eddies was the lowest among the 
three tested groups. 
Electron microscopic features of papillary uro-
thelial neoplasms with urothelial eddies
The papillary urothelial neoplasms with urothe-
lial eddies showed wide intercellular space 
(Figure 3A) with many cytoplasmic microvillous 
projections (Figure 3B). In the normal urotheli-
um, however, the intercellular space was incon-
spicuous and the microvillous projections were 
not as prominent as papillary urothelial neo-
plasms with urothelial eddies (Figure 3C and 
3D). Furthermore, well-developed desmosomes 
Figure 1. Cystoscopy and histology of papillary urothelial neoplasms with urothelial eddies (patients 9 and 7). A: 
Cystoscopic photograph shows papillary mass (patient 9). B-F: The histologic examination revealed papillary prolif-
eration of tumor cells (B) with frequent inverted growth pattern (C), urothelial eddies, which are small ovoid nests of 
cells arranged in an onion-skin pattern (D), wide intercellular space and cytoplasmic processes within the intercel-
lular spaces (E), and microinvasion of tumor cells within the stalk of the papillae (F). (B and F: patient 5; C-E: patient 
7; hematoxylin and eosin stain; original magnification: B and C: ×200; D and F: ×400; E: ×1000).
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and keratinization, diagnostic and characteris-
tic ultrastructural features of squamous cells 
as shown in Figure 3E and 3F, were not evident. 
Clinical behavior of papillary urothelial neo-
plasms with urothelial eddies
During the mean follow-up period of 88.7 
months (range, 2-233 months), four patients of 
papillary urothelial neoplasms with urothelial 
eddies developed tumor recurrence: two 
patients experienced one recurrence, one 
patient experienced two recurrences, and 
another one patient experienced three recur-
rences (Table 2). All recurrences were non-inva-
sive papillary tumors except for patient five, 
whose original and recurrent tumors were of 
low grade with microinvasion within the papil-
lary stalks. Two patients showed similar histo-
logic features to their original tumor with wide 
intercellular space but the onion-skin pattern 
was inconspicuous. The recurrent tumors of 
the other two patients were conventional papil-
lary urothelial carcinoma without urothelial 
eddies. None of the patients developed tumor 
progression in terms of grade and stage. 
Neither muscle-invasive recurrence nor urothe-
lial carcinoma specific death was noted; how-
ever, two patients died of other causes: one of 
gastric adenocarcinoma and the other one in a 
traffic accident.
Figure 2. Immunohistochemistry of papillary urothelial neoplasms with uro-
thelial eddies. The tumor showed high expressions of GATA3 (A), S100P (B), 
cytokeratin 7 (C), p63 (D), and low expressions of high molecular weight cyto-
keratin (E), thrombomodulin (F), p53 (G), and Ki-67 (H). Uroplakin III expres-
sion was noted as surface membranous pattern (arrow head) (I). Although 
surface urothelial cells (arrow head) are positive, the tumor cells are nega-
tive for cytokeratin 20 (J). (Original magnification: A-J: ×400).
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Discussion 
In this report, urothelial eddy, a distinct histo-
logic pattern of papillary urothelial neoplasm, is 
presented for the first time. Although urothelial 
eddy is morphologically reminiscent of squa-
mous differentiation, it is urothelial in nature 
and the tumor appears to follow an indolent 
clinical course with a low risk of tumor progres-
sion and cancer-related death. Awareness of 
papillary urothelial neoplasms with urothelial 
eddies has two pathologic implications: dis-
criminating urothelial eddies from squamous 
differentiation of urothelial carcinoma and the 
correct grading of the tumors.
Squamous differentiation, defined by the pres-
ence of intercellular bridges and/or keratiniza-
tion, is a relatively common phenomenon in 
urothelial carcinoma and is identified in up to 
60% of patients with this disease [1, 3]. It is 
associated with high tumor grade and advanced 
tumor stage [8]. Although it is not clear whether 
the poor clinical outcome is a reflection of the 
histology or the advanced stage of the disease, 
squamous differentiation portends high rates 
of tumor recurrence and progression and poor 
cancer specific survival [8, 9]. Furthermore, 
squamous differentiation appears to predict a 
poor response to chemotherapy, radiotherapy, 
and surgery in urothelial carcinoma patients [2, 
4]. Therefore, the presence or absence of squa-
mous differentiation should be included in the 
surgical pathology report [1]. 
By contrast, papillary urothelial neoplasms with 
urothelial eddies appears to have indolent clini-
cal course given that none of the 10 patients 
progressed to muscle-invasive tumor or died of 
the disease during the mean 88.7 months fol-
low-up period. The wide intercellular spaces 
with cytoplasmic processes mimicking intercel-
lular bridges in urothelial eddies may cause 
confusion with squamous differentiation of uro-
thelial carcinoma on histologic examination. On 
electron microscopy, normal urothelial cells 
showed inconspicuous intercellular spaces 
with a few small cytoplasmic microvillous pro-
jections. By contrast, papillary urothelial neo-
plasms with urothelial eddies demonstrated 
Figure 3. Electron microscopy of papillary urothelial neoplasms with urothelial eddies (A and B), normal urothelium 
of the urinary bladder (C and D) and normal squamous epithelium of the esophagus (E and F). Arrows indicate 
cytoplasmic microvillous projections of papillary urothelial neoplasms with urothelial eddies (B) and the normal 
urothelial cells (D) and desmosomes of normal squamous cells (F). (Original magnification: left column, ×8000; left 
column, ×15000).
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wide intercellular spaces and many prominent 
cytoplasmic microvillous projections, which cre-
ated superficial resemblance of intercellular 
bridges on histologic examination. However, 
keratinization and well-formed desmosomes, 
as seen in squamous cells, were not evident in 
papillary urothelial neoplasms with urothelial 
eddies. Furthermore, at the immunohistochem-
ical level, papillary urothelial neoplasms with 
urothelial eddies has a different immunoprofile 
from squamous cell carcinoma, but is similar to 
conventional urothelial carcinoma with a high 
expression of GATA3, S100P, CK7, and uropla-
kin III, and low expressions of HMWCK and 
p53. Based on our immunohistochemical and 
ultrastructural findings, papillary urothelial neo-
plasms with urothelial eddies appears to be of 
urothelial rather than squamous origin. 
There was a tendency for papillary urothelial 
neoplasms with urothelial eddies to be diag-
nosed as a higher grade. After the review by a 
GU pathologist, five patients were downgraded 
from low grade (1973 WHO grade 2) to PUNLMP 
(1973 WHO grade 1). This was probably due to 
the architectural and nuclear distortions as a 
result of onion-skin pattern and indented 
nuclei. Nevertheless, these patients did not 
show further architectural and nuclear atypia of 
higher grade tumor, including conspicuous loss 
of polarity at low magnification, chromatin 
clumping, prominent nucleoli, or brisk mitotic 
activity [10]. Therefore, this study suggests that 
squamous differentiation should be obvious to 
be stated in the pathology report and we rec-
ommend to avoid the term of “squamoid” dif-
ferentiation based on polygonal cell appear-
ance only without convincing evidence of 
intercellular bridges, keratinization or both.
The squamous eddy is a characteristic feature 
of irritated follicular keratosis, which is a benign 
inverted proliferative lesion of squamous cells 
in the skin and considered as a variant of seb-
orrheic keratosis [11]. Previous reports suggest 
that squamous eddies formed by focal matura-
tion of resting basaloid cells into squamous 
cells by irritation-induced activation [12, 13]. 
An increased apoptotic activity was reported in 
the squamous eddy [14]. Based on these find-
ings, squamous eddies are suggested to be an 
involution phase of the skin lesion [14]. 
Interestingly, papillary urothelial neoplasms 
with urothelial eddies patients also frequently 
showed an inverted growth pattern (6 out of 10 
patients, 60%) similar to irritated follicular kera-
tosis. Although apoptotic activity was not 
assessed in this study, papillary urothelial neo-
plasms with urothelial eddies showed the low-
est Ki-67 labeling index among the three groups 
tested. These findings may point to the non-
aggressive nature of the disease. 
Limitations of this study are its retrospective 
design and small number of patients. We did 
not provide a mechanistic explanation of uro-
thelial eddy formation, although apoptosis with 
low proliferative activity as demonstrated by 
the low Ki67 activity in this study might have a 
role in the pathogenesis of the unusual histol-
ogy. Therefore, further studies on a large num-
ber of patients are warranted to confirm its 
indolent clinical course.
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